Labcorp HoldingsLH +1.85%79 Net Margin % is 7.85% as of Mar. 2026, which is 3% above its 10-year median of 7.63. GuruFocus rates LH with a GF Score™ of 79/100 and a GF Value™ of $271.41 (Fairly Valued). The stock has 6 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Labcorp Holdings ranks better than 68.14% on this metric.
The historical rank and industry rank for Labcorp Holdings's Net Margin % or its related term are showing as below:
LH'
s Net Margin % Range Over the Past 10 Years
Min: 3.44 Med: 7.63 Max: 18.1
Current: 6.66
LH's Net Margin % is ranked better than 68.14% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: -2.405
vs LH: 6.66
Labcorp Holdings (NYSE:LH) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Labcorp Holdings Net Margin % Related Terms
Labcorp Holdings Net Margin % Historical Data
* Premium members only.
The historical data trend for Labcorp Holdings's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Labcorp Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labcorp Holdings Net Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Labcorp Holdings's Net Margin % distribution charts can be found below:
* The bar in red indicates where Labcorp Holdings's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Labcorp Holdings (LH) has a Net Margin % of 7.85% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Labcorp Holdings and its competitors. This is near median its historical median of 7.63. Over the past decade, Labcorp Holdings' Net Margin % has ranged from 3.44 to 18.10. According to the industry distribution chart, Labcorp Holdings ranks #65 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 31.9%.
Is Labcorp Holdings' Net Margin % too high?
Labcorp Holdings' current Net Margin % of 7.85% is near median its 10-year median of 7.63. Over the past 10 years, this metric has ranged from a low of 3.44 to a high of 18.10. Based on the distribution chart, Labcorp Holdings ranks #65 out of 204 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Labcorp Holdings has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Labcorp Holdings' Net Margin % compare to DGX and MTD?
According to the Medical Diagnostics & Research industry distribution chart, Labcorp Holdings ranks #65 out of 204 companies for Net Margin %. This puts Labcorp Holdings in the upper half of its industry. Historically, Labcorp Holdings' own Net Margin % has ranged from 3.44 to 18.10 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Diagnostics & Research company?
A good Net Margin % depends on the Medical Diagnostics & Research industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Labcorp Holdings and its competitors. Labcorp Holdings's current Net Margin % is 7.85%, which is near median its own 10-year median of 7.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labcorp Holdings stock overvalued right now?
Based on GuruFocus' analysis, Labcorp Holdings (LH) is currently considered Fairly Valued. The stock's GF Value™ is $271.41, compared to a current price of $270.08 — trading 0.5% below its estimated fair value. The current Net Margin % is 7.85%, which is near median its 10-year median of 7.63. Labcorp Holdings' overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Labcorp Holdings (LH), the current Net Margin % is 7.85% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Labcorp Holdings (LH) Overvalued in 2026?
Based on GuruFocus' analysis, Labcorp Holdings stock appears to be undervalued.
The current stock price of $270.08 is trading 0.5% below its estimated GF Value™ of $271.41.
GuruFocus considers Labcorp Holdings to be Fairly Valued.
Key valuation signals for LH:
Net Margin %: 7.85% (near median its 10-year median of 7.63)
GF Value™: $271.41 vs. price of $270.08 (0.5% below fair value)
No single metric tells the full story. See the LH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
79GF Score
Get the complete analysis for LH
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LH has been successfully added to your 
